Efficacy Study of Apremilast (CC-10004) in Subjects With Erosive Hand Osteoarthritis

NCT01200472 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Erosive Osteoarthritis of the Hand

Interventions

DRUG: Apremilast
DRUG: Placebo

Sponsor

University of Erlangen-Nürnberg Medical School

Collaborators

[object Object]